The Cancer Letter

Inside information on cancer research and drug development

Vol.
22
No.
17
April 26, 1996Apr 26, 1996
Free
DOWNLOAD THE PDF

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

Centers May Become More specialized, Klausner Tells AACI

NIH, NCI Being Discussions With HCFA On Reimbursement

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account